Publication:
Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort

Simple item page
dc.contributor.authorsKorten, V.; Inan, A.; Akalin, H.; Gokengin, D.; Kaya, B.; Inan, D.; Ozdemir, H. Ozkan; Azak, E.; Dogru, A.; Dokuzoguz, B.; Yildirmak, T.; Kose, S.; Karaoglan, I.
dc.date.accessioned2022-03-10T18:00:02Z
dc.date.accessioned2026-01-11T15:26:15Z
dc.date.available2022-03-10T18:00:02Z
dc.date.issued2019
dc.identifier.doidoiWOS:000494690300112
dc.identifier.eissn1468-1293
dc.identifier.issn1464-2662
dc.identifier.urihttps://hdl.handle.net/11424/222258
dc.identifier.wosWOS:000494690300112
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofHIV MEDICINE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleClinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage58
oaire.citation.startPage58
oaire.citation.titleHIV MEDICINE
oaire.citation.volume20

Files

Collections

Araştırma Çıktıları